Compare EVCM & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVCM | CLDX |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.9B |
| IPO Year | 2021 | 2008 |
| Metric | EVCM | CLDX |
|---|---|---|
| Price | $12.09 | $27.27 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 10 |
| Target Price | $11.50 | ★ $44.10 |
| AVG Volume (30 Days) | 396.6K | ★ 763.6K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $718,038,000.00 | $2,599,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.60 | $19.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 22.13 | N/A |
| 52 Week Low | $7.66 | $14.40 |
| 52 Week High | $14.41 | $30.50 |
| Indicator | EVCM | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 61.18 | 53.01 |
| Support Level | $11.57 | $24.97 |
| Resistance Level | $14.41 | $28.79 |
| Average True Range (ATR) | 0.84 | 1.41 |
| MACD | 0.26 | -0.26 |
| Stochastic Oscillator | 58.08 | 41.58 |
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.